Sort
25,944 grants matching “neurodegeneration”
Mechanisms of neurodegeneration in a porcine model of diet-induced CVD
$222,465Stefania Lamon-Fava · Tufts University Boston · R21 · FY2019 · AG
Lead Optimization of CRAC Channel Inhibitors for the Treatment of Alzheimer's Disease
$222,453Milton L Greenberg · Vivreon Biosciences, Llc · R44 · FY2016 · AG
Exploring FOXO Signaling in Promoting Neurodegeneration in AD
$222,420Kavita Shah · Purdue University · R21 · FY2015 · AG
Membrane binding and aggregation of alpha-synuclein
$222,382Jean-Christophe Rochet · Purdue University · R01 · FY2008 · NS
Eat-Me Signaling Cascade in the Apoptotic Cell Engulfment
$222,334Joseph C Ayoob · University Of Pittsburgh At Pittsburgh · R21 · FY2013 · AI
Sensory and Motor Streams in Preclinical and Clinical Stages of Alzheimer's Disease
$222,258Jorge Sepulcre · Massachusetts General Hospital · R01 · FY2023 · AG
Identifying novel therapeutics for early onset dystonia
$222,136David Cristopher Bragg · Massachusetts General Hospital · R21 · FY2009 · NS
PROTEIN PROTEIN INTERACTIONS DURING PRION PROTEIN BIOGENESIS
$222,100University Of California San Francisco · P01 · FY2000 · AG
In Vivo Lentiviral Gene Therapy for Hurler Syndrome
$222,057Chester B Whitley · University Of Minnesota · P01 · FY2011 · HD
Pesticide Exposure and Age-Related Changes in Cognitive Function
$222,000Ha T Nguyen · Wake Forest University Health Sciences · R21 · FY2011 · ES
The contribution of late onset unexplained epilepsy to cognitive decline and its interaction with vascular and Alzheimer's disease pathologies
$221,956Rani Sarkis · Brigham And Women'S Hospital · K23 · FY2022 · NS
GENETIC CONTROL OF NEUROMUSCULAR DEGENERATION IN MICE
$221,953Jackson Laboratory · R01 · FY2000 · NS
Cell cycle re-entry in the aging adult brain
$221,938Laura A Buttitta · University Of Michigan At Ann Arbor · R21 · FY2015 · AG
Mouse models for decoding microRNA regulation in diverse tissues and cell types
$221,875Ian John Macrae · Scripps Research Institute, The · R21 · FY2021 · OD
G-quadruplex Structures as Targets and Tools in ALS
$221,875Pavel Ivanov · Brigham And Women'S Hospital · R21 · FY2016 · NS
Do allergens contribute to neurodegeneration?
$221,875Bruno Conti · San Diego Biomedical Research Institute · R21 · FY2021 · NS
Exploiting PrP for the diagnosis and treatment of protein aggregation diseases
$221,823Dominic Martin Walsh · Brigham And Women'S Hospital · R21 · FY2015 · AG
Integrating Genomic Signatures with Functional Analysis of DNA repair
$221,807Zachary David Nagel · Broad Institute, Inc. · R21 · FY2025 · ES
Attenuating sterol synthesis in WT and NPC mice brains
$221,804Dartmouth College · R21 · FY2005 · NS
ACUTE BRAIN INJURY, MECHANISMS AND PROTECTION
$221,738Washington University · R01 · FY2001 · HD
Circadian Timekeeping, Oxidative Stress and Metabolism in ALS Models
$221,730Marcelo R Vargas · Medical University Of South Carolina · R21 · FY2018 · NS
Pathophysiology of Transgenic Mouse Models of Huntington's Disease
$221,725Michael S. Levine · University Of California Los Angeles · R01 · FY2011 · NS
Neuroprotective drugs for A-T
$221,710David Wassarman · University Of Wisconsin-Madison · R21 · FY2013 · NS
Activation of PPAR-gamma in a Monkey Model of Cardiac Dysautonomia
$221,710Marina Emborg · University Of Wisconsin-Madison · R21 · FY2015 · NS
HIV Effects on Astrocyte Function and Astrocyte-Neuronal Interactions
$221,621David J Volsky · St. Luke'S-Roosevelt Inst For Hlth Scis · P01 · FY2007 · NS